162 related articles for article (PubMed ID: 15748152)
1. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.
Mestre L; Correa F; Arévalo-Martín A; Molina-Holgado E; Valenti M; Ortar G; Di Marzo V; Guaza C
J Neurochem; 2005 Mar; 92(6):1327-39. PubMed ID: 15748152
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.
Correa F; Hernangómez-Herrero M; Mestre L; Loría F; Docagne F; Guaza C
Brain Behav Immun; 2011 May; 25(4):736-49. PubMed ID: 21310228
[TBL] [Abstract][Full Text] [Related]
3. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.
Ortega-Gutiérrez S; Molina-Holgado E; Arévalo-Martín A; Correa F; Viso A; López-Rodríguez ML; Di Marzo V; Guaza C
FASEB J; 2005 Aug; 19(10):1338-40. PubMed ID: 15941768
[TBL] [Abstract][Full Text] [Related]
4. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
5. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Hernangómez M; Mestre L; Correa FG; Loría F; Mecha M; Iñigo PM; Docagne F; Williams RO; Borrell J; Guaza C
Glia; 2012 Sep; 60(9):1437-50. PubMed ID: 22653796
[TBL] [Abstract][Full Text] [Related]
6. Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Iwahashi T; Inoue A; Koh CS; Shin TK; Kim BS
Cell Immunol; 1999 Jun; 194(2):186-93. PubMed ID: 10383821
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 and interleukin-10 modulate nuclear factor kappaB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes.
Molina-Holgado E; Arévalo-Martín A; Castrillo A; Boscá L; Vela JM; Guaza C
J Neurochem; 2002 Jun; 81(6):1242-52. PubMed ID: 12068072
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.
Eljaschewitsch E; Witting A; Mawrin C; Lee T; Schmidt PM; Wolf S; Hoertnagl H; Raine CS; Schneider-Stock R; Nitsch R; Ullrich O
Neuron; 2006 Jan; 49(1):67-79. PubMed ID: 16387640
[TBL] [Abstract][Full Text] [Related]
10. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway.
Molina-Holgado F; Molina-Holgado E; Guaza C
FEBS Lett; 1998 Aug; 433(1-2):139-42. PubMed ID: 9738948
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Takeichi N; Yanagisawa S; Kaneyama T; Yagita H; Jin YH; Kim BS; Koh CS
Int Immunol; 2010 Sep; 22(9):729-38. PubMed ID: 20685674
[TBL] [Abstract][Full Text] [Related]
12. Theiler's virus infection: a model for multiple sclerosis.
Oleszak EL; Chang JR; Friedman H; Katsetos CD; Platsoucas CD
Clin Microbiol Rev; 2004 Jan; 17(1):174-207. PubMed ID: 14726460
[TBL] [Abstract][Full Text] [Related]
13. 2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.
Mecha M; Feliú A; Machín I; Cordero C; Carrillo-Salinas F; Mestre L; Hernández-Torres G; Ortega-Gutiérrez S; López-Rodríguez ML; de Castro F; Clemente D; Guaza C
Glia; 2018 Jul; 66(7):1447-1463. PubMed ID: 29484707
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic action of cannabinoids in a murine model of multiple sclerosis.
Arévalo-Martín A; Vela JM; Molina-Holgado E; Borrell J; Guaza C
J Neurosci; 2003 Apr; 23(7):2511-6. PubMed ID: 12684434
[TBL] [Abstract][Full Text] [Related]
15. 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.
Feliú A; Bonilla Del Río I; Carrillo-Salinas FJ; Hernández-Torres G; Mestre L; Puente N; Ortega-Gutiérrez S; López-Rodríguez ML; Grandes P; Mecha M; Guaza C
J Neurosci; 2017 Aug; 37(35):8385-8398. PubMed ID: 28751457
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.
Gilli F; Li L; Royce DB; DiSano KD; Pachner AR
J Neurovirol; 2017 Dec; 23(6):825-838. PubMed ID: 28913765
[TBL] [Abstract][Full Text] [Related]
17. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
18. Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes.
Lipton HL; Kumar AS; Trottier M
Virus Res; 2005 Aug; 111(2):214-23. PubMed ID: 15893838
[TBL] [Abstract][Full Text] [Related]
19. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.
de Lago E; Ligresti A; Ortar G; Morera E; Cabranes A; Pryce G; Bifulco M; Baker D; Fernandez-Ruiz J; Di Marzo V
Eur J Pharmacol; 2004 Jan; 484(2-3):249-57. PubMed ID: 14744610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
